Skip to content

Study of CO2 fractional laser treatment for GSM

A comparative study of patient QOL with different probes in CO2 fractional laser treatment for Genitourinary Syndrome of Menopause (GSM)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032210633
Enrollment
100
Registered
2022-02-28
Start date
2022-02-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genitourinary Syndrome of Menopause Genitourinary Syndrome of Menopause

Interventions

The content of the intervention is to use a laser probe with a 360 deg attachment. The laser program is the same intravaginally irradiate the target patient with CO2 laser 3 times a month Irradiation

Sponsors

Suzuki Nao
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Patients aged 20 years or older with a diagnosis of GSM 2) Patients who wish to receive CO2 fractional laser treatment 3) Patients have given written consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients with dysplastic lesions of the cervix, vagina, and vulva 2) Patients with active pelvic infections 3) Unexplained genital bleeding 4) Patients with vaginal and / or cervical wounds 5) Patients with advanced malignant tumors and severe co-morbidities 6) Patients who have already received CO2 fractional laser treatment for GSM 7) Patients judged by the investigator to be inappropriate

Design outcomes

Primary

MeasureTime frame
NRS scores for pain investigated immediately after the first treatment

Secondary

MeasureTime frame
Efficacy: Vaginal epithelial maturity (cytodiagnosis), vaginal environment (vaginal pH), patient QOL questionnaire survey score Usefulness: NRS scores for pain investigated immediately after the second treatment, Number of cases by probe selected by the study subject at the time of the third treatment

Contacts

Public ContactAkiko Tozawa

St. Marianna University School of Medicine

a2ono@marianna-u.ac.jp+81-44-977-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026